TrialInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2021

Randomized controlled open label trial on the use of favipiravir combined with inhaled interferon beta-1b in hospitalized patients with moderate to severe COVID-19 pneumonia.

Faryal Khamis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.